Results 71 to 80 of about 88,264 (269)

sj-jpg-2-cll-10.1177_09636897231173736 – Supplemental material for Exosomes From Adipose-Derived Stem Cells Suppress the Progression of Chronic Endometritis

, 2023
Supplemental material, sj-jpg-2-cll-10.1177_09636897231173736 for Exosomes From Adipose-Derived Stem Cells Suppress the Progression of Chronic Endometritis by Bin Wang, Li Li and Ruizhu Yu in Cell ...
Ruizhu Yu (15524156), Bin Wang (30851), Li Li (14993)   +2 more
core   +1 more source

Nanomedicine‐driven innovations in postoperative cancer immunotherapy: Remodeling tumor microenvironment and precision delivery strategies

BMEMat, EarlyView.
Nanomedicine‐Driven Strategies for Suppressing Postoperative Tumor Recurrence. This schematic illustrates three pivotal nanomedical strategies that synergistically counteract recurrence by targeting residual disease and the immunosuppressive tumor microenvironment within the surgical cavity.
Lisong Pang, Zhuomin Wang, Zhenhua Jin, Ahmed H. Ghonaim, Hengcheng Zhang, Xinyu You, Jinzhuo Ning, Jiaqing Cao, Yang Liu   +8 more
wiley   +1 more source

IGHV Mutational Status in a Cohort of Bulgarian CLL Patients: High Unmutated CLL Prevalence in North-East Bulgaria

Balkan Journal of Medical Genetics
Chronic lymphocytic leukemia (CLL) is the most common leukemia in adults. One of the best established CLL prognostic markers is the somatic hypermutational status of the IGHV gene which is a part of the immunoglobulin heavy chain variable region ...
Yosifova A, Micheva I, Donchev M, Tincheva S, Ormandjiev S, Genova J, Pavlova Z, Todorova A   +7 more
doaj   +1 more source

Coexistence of immunophenotypically normal and aberrant mast cells in patients with clonal mast cell diseases associates with more indolent subtypes and less severe disease characteristics

Cytometry Part B: Clinical Cytometry, EarlyView.
Abstract Aberrant antigen expression on mast cells (MCs) is one of the most accurate diagnostic markers for clonal MC diseases (CMCD). Although the coexistence of normal and pathologic MCs is frequently seen, the disease characteristics associated with it have been minimally investigated.
Abdulrazzaq Alheraky, Kees Meijer, Marije Nijk, Saskia K. Klein, Hanneke N. G. Oude Elberink, Ido P. Kema, André B. Mulder   +6 more
wiley   +1 more source

Neoadjuvant Cemiplimab for Resectable Locoregionally Advanced Cutaneous Squamous Cell Carcinoma: A Case Series

Head &Neck, EarlyView.
ABSTRACT Introduction A Phase II trial demonstrated that neoadjuvant cemiplimab was associated with pathologic complete response (pCR) in 51% of patients with locoregionally advanced cutaneous squamous cell carcinoma (cuSCC). We evaluated real‐world radiographic and pathologic responses to neoadjuvant cemiplimab and assessed radiologic–pathologic ...
Whitney Jin, Ryan K. Rigsby, Kim Ely, Austin Hoke, Robert Sinard, Kyle Mannion, Jill Gilbert, Lindsay Mundy, Alexander Langerman, Sarah Rohde, Barbara Murphy, Eben Rosenthal, Mitra Mehrad, Michael C. Topf, Jennifer H. Choe   +14 more
wiley   +1 more source

Risk of Developing Subsequent Primary Colorectal Cancers Among Non‐Colorectal Cancer Survivors: Implications for Prevention and Screening

International Journal of Cancer, EarlyView.
ABSTRACT Cancer survivors have an elevated risk of developing subsequent primary cancers, including colorectal cancer (CRC), and may benefit from tailored screening approaches to reduce incidence and morbidity. A retrospective cohort of adults diagnosed with cancer (excluding CRC) in Alberta, Canada from 2000 to 2021 who survived at least 6 months was ...
Dylan E. O'Sullivan, Robert J. Hilsden, Hannah Harsanyi, Matthew T. Warkentin, Kareem Jamani, Huiming Yang, Darren R. Brenner, Safiya Karim, Winson Y. Cheung, Yibing Ruan   +9 more
wiley   +1 more source

CYP3A4 and CYP3A5 Genes in Cyclophosphamide-treated Chronic Lymphocytic Leukemia Patients: A Pharmacogenetics Study

Frontiers in Bioscience-Scholar
Background: Approximately 75% of drug metabolism in clinical settings is attributed to cytochrome P450 enzymes. This study aimed to assess the effects of the CYP3A4*1B and CYP3A5*3 genetic variations on the clinical results of ...
Heba M. Elmaraghy, Menna Al-Adl, Eman R. Saifeldein, Sahar M. Elashmony, Magdy M. Youssef, Afaf El-Said, Sherif Refaat, Abdallah E. Mohammed   +7 more
doaj   +1 more source

sj-docx-3-cll-10.1177_09636897221133345 – Supplemental material for Intrauterine Injection of Umbilical Cord Mesenchymal Stem Cell Exosome Gel Significantly Improves the Pregnancy Rate in Thin Endometrium Rats

, 2022
Supplemental material, sj-docx-3-cll-10.1177_09636897221133345 for Intrauterine Injection of Umbilical Cord Mesenchymal Stem Cell Exosome Gel Significantly Improves the Pregnancy Rate in Thin Endometrium Rats by Shengning Zhang, Dongmei Wang, Fang Yang ...
Yanjun Shen (389969), Dongmei Wang (282313), Fang Yang (123514), Shengning Zhang (14054863), Dong Li (212687), Xiaohui Deng (534130)   +5 more
core   +1 more source

Double‐VISTA technique with connective tissue graft or acellular dermal matrix for treating multiple recessions associated with non‐carious cervical lesions: A retrospective study

Journal of Periodontology, EarlyView.
Abstract Background This retrospective study evaluated whether clinical outcomes differed between connective tissue graft (CTG) and allogeneic solvent‐dehydrated acellular dermal matrix (ADM) for treating multiple gingival recessions associated with non‐carious cervical lesions (NCCLs) using partial restoration and the double‐vestibular incision ...
Guo‐Hao Lin, Lan‐Lin Chiou, Yu‐Ting Yeh, Shayan Barootchi, Lorenzo Tavelli, Homayoun H. Zadeh, Hom‐Lay Wang   +6 more
wiley   +1 more source

Effect of IGHV Gene Mutation Status and BCR Structure Stereotypy on Effectiveness of BR Regimen in First-Line Therapy of Chronic Lymphocytic Leukemia

Клиническая онкогематология, 2017
Background & Aims. The IGHV gene mutation status is a constant biological feature of tumor cells in chronic lymphocytic leukemia (CLL). This parameter is an important predictor of the efficacy of immunochemotherapy.
Vladimir Vladimirovich Strugov, E. A. Stadnik, A. M. Rumyantsev, T. O. Andreeva, Yu. V. Virts, Yu. V. Mirolyubova, P. A. Butylin, A. Yu. Zaritskey   +7 more
doaj   +1 more source